These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29619858)

  • 41. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
    Gündoğdu KÖ; Doğan E; Çelik E; Alagöz G
    J Diabetes Complications; 2022 Jul; 36(7):108228. PubMed ID: 35691875
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
    Xu Y; Rong A; Xu W; Niu Y; Wang Z
    BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI WITH VISUAL OUTCOMES IN DIFFERENT PATTERNS OF DIABETIC MACULAR EDEMA.
    Kang JW; Chung H; Chan Kim H
    Retina; 2016 Sep; 36(9):1630-9. PubMed ID: 26900741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY.
    Fickweiler W; Schauwvlieghe AME; Schlingemann RO; Maria Hooymans JM; Los LI; Verbraak FD;
    Retina; 2018 Apr; 38(4):812-819. PubMed ID: 28406860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RANIBIZUMAB FOR MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION: One Initial Injection Versus Three Monthly Injections.
    Miwa Y; Muraoka Y; Osaka R; Ooto S; Murakami T; Suzuma K; Takahashi A; Iida Y; Yoshimura N; Tsujikawa A
    Retina; 2017 Apr; 37(4):702-709. PubMed ID: 27471827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ranibizumab treatment improves diabetic macular oedema without influencing retinal oximetry parameters.
    Takasago Y; Fujita T; Nakano Y; Osaka R; Miyake M; Muraoka Y; Tsujikawa A
    Acta Ophthalmol; 2019 Dec; 97(8):e1048-e1053. PubMed ID: 31127694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.
    Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
    Prager SG; Lammer J; Mitsch C; Hafner J; Pemp B; Scholda C; Kundi M; Schmidt-Erfurth U; Kriechbaum K
    Acta Ophthalmol; 2018 Mar; 96(2):e195-e200. PubMed ID: 29063703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema.
    Mori Y; Suzuma K; Uji A; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Murakami T
    Sci Rep; 2016 Dec; 6():39161. PubMed ID: 27966644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of ranibizumab on visual impairment in patients with bilateral diabetic macular edema.
    Fajnkuchen F; Pieramici D; Hrarat L; Best AL; Cohen SY; Delahaye-Mazza C; Grenet T; Nghiem-Buffet S; Quentel G; Bodaghi B; Giocanti-Aurégan A
    Acta Diabetol; 2019 Jan; 56(1):67-71. PubMed ID: 30167869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P; Parodi MB; Scaramuzzi M; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
    Narayanan R; Panchal B; Das T; Chhablani J; Jalali S; Ali MH;
    Br J Ophthalmol; 2015 Jul; 99(7):954-9. PubMed ID: 25631483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases.
    Chen YP; Wu AL; Chuang CC; Chen SN
    Sci Rep; 2019 Jul; 9(1):10952. PubMed ID: 31358777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy.
    Ogino K; Tsujikawa A; Yamashiro K; Ooto S; Oishi A; Nakata I; Miyake M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3771-9. PubMed ID: 23661367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.
    Minami Y; Nagaoka T; Ishibazawa A; Yoshida A
    BMC Ophthalmol; 2017 Mar; 17(1):28. PubMed ID: 28292270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
    Domalpally A; Ip MS; Ehrlich JS
    Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.